Blondis, MRI glioma 28 yr old male, marked as public domain, details at...
Blondis, MRI glioma 28 yr old male, marked as public domain, details at Wikimedia Commons
20.01.2020 •

AI & MRI look into the genome of brain tumors

Researchers at Osaka University have developed a computer method that uses magnetic resonance imaging (MRI) and machine learning to rapidly forecast genetic mutations in glioma tumors, which occur in the brain or spine. The work may help glioma patients to receive more suitable treatment faster, giving better outcomes.

Cancer treatment has undergone a revolution in recent years. Spurred by recognition that each cancer case is unique, the specific genetic mutations tumor cells carry are now sequenced to discover which chemotherapy drugs will work best. However, certain types of cancer, especially brain tumors, are less accessible for genetic testing. The tumor’s genotype can’t be found until a sample is taken during surgery, and this can significantly delay treatment.

Glioma is a type of cancer that originates in the brain’s supporting cells. Two types of mutations are especially important; these are changes in the gene for the enzyme isocitrate dehydrogenase (IDH) or the promoter region of telomerase (TERT). Identifying these mutations can help direct the proper course of treatment. The researchers produced a machine-learning algorithm that can predict which mutations are present using only the MR images of the tumors. “Machine learning is increasingly used to diagnose medical images. But our work is one of the first to even attempt to classify something as hidden as the genotype based on image data alone,” study first author Ryohei Fukuma explains. The algorithm was found to be significantly better at predicting the mutations compared with conventionally used radiomic features of the MR images, such as size, shape, and intensity.

To construct the algorithm, the researchers used a convolutional neural network to extract features from the MR images. Then, using a machine-learning method called support vector machines, they classified the patients into groups based on the presence or absence of mutations. “We hope to expand this approach to other types of cancer, so we can take advantage of the large cancer gene databases already collected” senior author Haruhiko Kishima says. The end result could remove the need for surgical tissue sampling. Even more, it could lead to better clinical outcomes for patients as the process of delivering personalized medicine becomes easier and faster.

Subscribe to our newsletter

Related articles

AI and laser-based imaging system identify brain tumors

AI and laser-based imaging system identify brain tumors

A novel method of combining advanced optical imaging with an artificial intelligence algorithm produces accurate, real-time intraoperative diagnosis of brain tumors.

AI predicts effectiveness of immunotherapy

AI predicts effectiveness of immunotherapy

Scientists can determine which lung-cancer patients will benefit from expensive immunotherapy.

AI predicts survival of ovarian cancer patients

AI predicts survival of ovarian cancer patients

Researchers have created new machine learning software that can forecast the survival rates and response to treatments of patients with ovarian cancer.

How many gender subtypes exist in the brain?

How many gender subtypes exist in the brain?

New machine learning study suggest the presence of at least nine gender “expressions”.

AI may alter how doctors treat depression

AI may alter how doctors treat depression

Artificial intelligence may soon play a critical role in choosing which depression therapy is best for patients.

Deep learning boosts MRI detection of ADHD

Deep learning boosts MRI detection of ADHD

Deep learning can boost the power of MRI in predicting attention deficit hyperactivity disorder (ADHD).

ConvPath software uses AI to identify cancer cells

ConvPath software uses AI to identify cancer cells

A software tool uses artificial intelligence to recognize cancer cells from digital pathology images — giving clinicians a powerful way of predicting patient outcomes.

Deep learning identifies molecular patterns of cancer

Deep learning identifies molecular patterns of cancer

An AI platform can analyze genomic data extremely quickly, picking out key patterns to classify different types of colorectal tumors and improve the drug discovery process.

Facial recognition software IDs individuals from MRI scans

Facial recognition software IDs individuals from MRI scans

Though identifying data typically are removed from medical image files before they are shared for research, a study finds that this may not be enough to protect patient privacy.

Popular articles